Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of Toronto
$27,000.00
Assessing ERG as a Therapeutic to Reverse EndMT and Restore Endothelial Cell Identity in Atherosclerosis
FY 2025-26
Summary
Atherosclerosis is a major risk factor for heart disease that involves the formation of a plaque (i.e., atherosclerosis) within blood vessels that can block blood flow and break off to cause stroke, heart attack, and death. Endothelial cells (ECs) form the innermost layer of blood vessels and are tightly packed to form a physical barrier between blood in the vessels and the tissues of the body. These cells also play crucial roles in regulating normal vessel and tissue function. Specifically, ERG, a gene expressed within ECs, has been shown to play an important role in maintaining normal EC behaviour. However, our lab has found that when ECs lose ERG, they begin to lose their function and the normally tight EC barrier becomes leaky. This causes fats and other molecules from tissue to pass through and collect within the blood vessel to form a plaque, resulting in atherosclerosis. However, the ability of ECs to regain their function after losing ERG and the potential for ERG to be used as a treatment for atherosclerosis has yet to be explored. My research aims to further investigate this. I hypothesize that delivering ERG back to ECs will allow them to function normally again and slow down atherosclerosis development. To study this, I will use a virus containing ERG that can deliver ERG back to ECs that have lost ERG. This will be used with human cell experiments to understand whether EC behaviour and function can be restored once ECs regain ERG. Alongside this, mice that have lost ERG will be given atherosclerosis and following delivery of ERG using virus, changes in plaque development will be studied. This work will ultimately help us understand the crucial role of ERG in ECs and help explore the potential for ERG to be used as a treatment for atherosclerosis.
Department
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
572710
Name
Ho Christy
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Assessing ERG as a Therapeutic to Reverse EndMT and Restore Endothelial Cell Identity in Atherosclerosis
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Atherosclerosis; Cardiovascular Disease; Cholesterol; Endmt; Endothelial Cells; Endothelial-To-Mesenchymal Transition; Erg; Ets-Related Gene; Immune Cells; Therapeutic
Abstract
Atherosclerosis is a major risk factor for heart disease that involves the formation of a plaque (i.e., atherosclerosis) within blood vessels that can block blood flow and break off to cause stroke, heart attack, and death. Endothelial cells (ECs) form the innermost layer of blood vessels and are tightly packed to form a physical barrier between blood in the vessels and the tissues of the body. These cells also play crucial roles in regulating normal vessel and tissue function. Specifically, ERG, a gene expressed within ECs, has been shown to play an important role in maintaining normal EC behaviour. However, our lab has found that when ECs lose ERG, they begin to lose their function and the normally tight EC barrier becomes leaky. This causes fats and other molecules from tissue to pass through and collect within the blood vessel to form a plaque, resulting in atherosclerosis. However, the ability of ECs to regain their function after losing ERG and the potential for ERG to be used as a treatment for atherosclerosis has yet to be explored. My research aims to further investigate this. I hypothesize that delivering ERG back to ECs will allow them to function normally again and slow down atherosclerosis development. To study this, I will use a virus containing ERG that can deliver ERG back to ECs that have lost ERG. This will be used with human cell experiments to understand whether EC behaviour and function can be restored once ECs regain ERG. Alongside this, mice that have lost ERG will be given atherosclerosis and following delivery of ERG using virus, changes in plaque development will be studied. This work will ultimately help us understand the crucial role of ERG in ECs and help explore the potential for ERG to be used as a treatment for atherosclerosis.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ho, Christy
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~